“…It has been suggested that the administration of Prernarin may reduce blood loss in patients following open intracardiac operations (Ambrus et al, 1971) and adenoidectomy (Menger, 1955). Premarin, a conjugated oestrogen substance, has been reported to cause an increase in Factors 1V and V levels (Johnson, 1957;Wayne et al, 1964) and in platelet aggregation (Elkeles et al, 1968), and to decrease capillary permeability (Maki et al, 1969) and circulating fibrinolytic activity in man (Villadolid et al, 1965).…”